Nalpropion Pharmaceuticals v. Actavis Laboratories Fl, Inc.
Court of Appeals for the Federal Circuit
1Opinion of the Court
Opinion dissenting in part filed by Chief Judge Prost.
Lourie, Circuit Judge.
*1346 Actavis Laboratories FL, Inc. ("Actavis") appeals from the judgment of the U.S. District Court for the District of Delaware that (1) its proposed naltrexone hydrochloride and bupropion hydrochloride extended-release tablets, which are the subject of Abbreviated New Drug Application No. 208043 (the "ANDA product"), would infringe claim 1 of U.S. Patent 7,375,111 ("the '111 patent"), claims 26 and 31 of U.S. Patent 7,462,626 ("the '626 patent"), and claim 11 of U.S. Patent 8,916,195 ("the '195 patent") ; (2) the…
Also in this document: Dissent.
2Cases cited25 opinions
- Anderson v. City of Bessemer CitySupreme Court of the United States · 1985
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- United States v. Yellow Cab Co.Supreme Court of the United States · 1949
- Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.Court of Appeals for the Federal Circuit · 2010
20 more not listed; retrieve them via the Exa API.
3Cited by8 opinions
- Allergan USA, Inc. v. Msn Laboratories Private Ltd.Court of Appeals for the Federal Circuit · 2024
- Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2025
- Alan Amron, echangingbarcode, LLC v. MLB, MLB ADVANCED MEDIA (MLBAM), Live Nation Entertainment (LNE), StubHub, and 30 national baseball teams and event stadiums (LNE and STUBHUB noticed as Voluntarily terminated by the Plaintiff) and Does I-XDistrict Court, S.D. New York · 2025
- Indivior Uk Limited v. Dr. Reddy"s Laboratories S.A.Court of Appeals for the Federal Circuit · 2021
- MHL Custom, Inc. v. Waydoo USA, Inc.District Court, D. Delaware · 2023
3 more not listed; retrieve them via the Exa API.